These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 31262980

  • 21. Vesicle-Mediated Dendritic Cell Activation in Acinetobacter baumannii Clinical Isolate, which Contributes to Th2 Response.
    Cai W, Kesavan DK, Cheng J, Vasudevan A, Wang H, Wan J, Abdelaziz MH, Su Z, Wang S, Xu H.
    J Immunol Res; 2019; 2019():2835256. PubMed ID: 32083139
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Toll‑like receptor 2 promotes bacterial clearance during the initial stage of pulmonary infection with Acinetobacter baumannii.
    Kim CH, Kim DJ, Lee SJ, Jeong YJ, Kang MJ, Lee JY, Choi JA, Kwon SJ, Park JH, Park JH.
    Mol Med Rep; 2014 Apr; 9(4):1410-4. PubMed ID: 24567035
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Depletion of Alveolar Macrophages Increases Pulmonary Neutrophil Infiltration, Tissue Damage, and Sepsis in a Murine Model of Acinetobacter baumannii Pneumonia.
    Lee HH, Aslanyan L, Vidyasagar A, Brennan MB, Tauber MS, Carrillo-Sepulveda MA, Dores MR, Rigel NW, Martinez LR.
    Infect Immun; 2020 Jun 22; 88(7):. PubMed ID: 32366576
    [Abstract] [Full Text] [Related]

  • 26. Pseudomonas aeruginosa outer membrane vesicles modulate host immune responses by targeting the Toll-like receptor 4 signaling pathway.
    Zhao K, Deng X, He C, Yue B, Wu M.
    Infect Immun; 2013 Dec 22; 81(12):4509-18. PubMed ID: 24082079
    [Abstract] [Full Text] [Related]

  • 27. Intranasal immunization with outer membrane vesicles (OMV) protects against airway colonization and systemic infection with Acinetobacter baumannii.
    Higham SL, Baker S, Flight KE, Krishna A, Kellam P, Reece ST, Tregoning JS.
    J Infect; 2023 Jun 22; 86(6):563-573. PubMed ID: 36858180
    [Abstract] [Full Text] [Related]

  • 28. [Establishment of Acinetobacter baumannii-induced pneumonia model in mice].
    Zhang Y, Zhou X, Zhang H, Huan C, Ye Z.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct 22; 33(10):1392-1397. PubMed ID: 29169425
    [Abstract] [Full Text] [Related]

  • 29. IL-33 Treatment Attenuates the Systemic Inflammation Reaction in Acinetobacter baumannii Pneumonia by Suppressing TLR4/NF-κB Signaling.
    Peng C, Han J, Ye X, Zhang X.
    Inflammation; 2018 Jun 22; 41(3):870-877. PubMed ID: 29508184
    [Abstract] [Full Text] [Related]

  • 30. RAGE-Mediated Suppression of Interleukin-10 Results in Enhanced Mortality in a Murine Model of Acinetobacter baumannii Sepsis.
    Noto MJ, Becker KW, Boyd KL, Schmidt AM, Skaar EP.
    Infect Immun; 2017 Mar 22; 85(3):. PubMed ID: 28052995
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Imaging of bioluminescent Acinetobacter baumannii in a mouse pneumonia model.
    Na SH, Oh MH, Jeon H, Lee YK, Lee B, Shin M, Lee JC.
    Microb Pathog; 2019 Dec 22; 137():103784. PubMed ID: 31600538
    [Abstract] [Full Text] [Related]

  • 35. Assessing Acinetobacter baumannii Virulence and Persistence in a Murine Model of Lung Infection.
    Palmer LD, Green ER, Sheldon JR, Skaar EP.
    Methods Mol Biol; 2019 Dec 22; 1946():289-305. PubMed ID: 30798564
    [Abstract] [Full Text] [Related]

  • 36. A lipopolysaccharide-free outer membrane vesicle vaccine protects against Acinetobacter baumannii infection.
    Pulido MR, García-Quintanilla M, Pachón J, McConnell MJ.
    Vaccine; 2020 Jan 22; 38(4):719-724. PubMed ID: 31843268
    [Abstract] [Full Text] [Related]

  • 37. NLRP3 inflammasome mediates interleukin-1β production in immune cells in response to Acinetobacter baumannii and contributes to pulmonary inflammation in mice.
    Kang MJ, Jo SG, Kim DJ, Park JH.
    Immunology; 2017 Apr 22; 150(4):495-505. PubMed ID: 28032341
    [Abstract] [Full Text] [Related]

  • 38. OmpA Protein-Deficient Acinetobacter baumannii Outer Membrane Vesicles Trigger Reduced Inflammatory Response.
    Skerniškytė J, Karazijaitė E, Lučiūnaitė A, Sužiedėlienė E.
    Pathogens; 2021 Mar 31; 10(4):. PubMed ID: 33807410
    [Abstract] [Full Text] [Related]

  • 39. Differential proteomic analysis and pathogenic effects of outer membrane vesicles derived from Acinetobacter baumannii under normoxia and hypoxia.
    Suzuki S, Subsomwong P, Narita K, Kawai N, Ishiai T, Teng W, Sukchawalit R, Nakane A, Tasaka S, Asano K.
    PLoS One; 2023 Mar 31; 18(3):e0283109. PubMed ID: 36920961
    [Abstract] [Full Text] [Related]

  • 40. Acinetobacter baumannii transfers the blaNDM-1 gene via outer membrane vesicles.
    Chatterjee S, Mondal A, Mitra S, Basu S.
    J Antimicrob Chemother; 2017 Aug 01; 72(8):2201-2207. PubMed ID: 28505330
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.